Cue Biopharma, Inc. (CUE) Net margin 2018–2025
Cue Biopharma, Inc. (CUE) net profit margin by fiscal year — reported net income divided by reported revenue.
-96.9%FY2025 · since FY2018: -3411.5% → -96.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -96.9% | +341.1 pp |
| FY2024 | -438.0% | +486.1 pp |
| FY2023 | -924.1% | +3333.7 pp |
| FY2022 | -4257.8% | -3962.3 pp |
| FY2021 | -295.6% | +1124.2 pp |
| FY2020 | -1419.8% | -358.6 pp |
| FY2019 | -1061.2% | +2350.4 pp |
| FY2018 | -3411.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice